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 1 
ABSTRACT 2 
Ethnopharmacological relevance: The oleoresin of Brazilian Copaifera reticulata is a 3 
traditional remedy used for the treatment of skin and urinary tract infections, respiratory 4 
diseases, rheumatism, ulcer and tumours; thus, playing an important role in the primary health 5 
care of the indigenous population.  6 
Aim: As most previous pharmacological tests used the crude oleoresin and only a few studies 7 
so far dealt with enriched fractions or pure chemically defined compounds, the aim of this study 8 
was to systematically evaluate the antimicrobial and cytotoxic properties of the Copaifera 9 
reticulata oleoresin and to assign traditional uses to specific secondary metabolites.  10 
Materials and methods: The oleoresin, as well as its neutral and acidic fractions were tested for 11 
their activity against six cancer cell lines, two clinically relevant bacterial strains, and two 12 
dermatophytes. Both fractions were analysed by GC-MS and UHPLC-ELSD, respectively. The 13 
antibacterial acidic phase was further fractionated by preparative chromatography to purify and 14 
characterize the compounds responsible for the observed pharmacological effect. 15 
Results: Whereas no cytotoxic activity was detected, the crude oleoresin and its acidic fraction 16 
showed antibacterial activity against gram-positive bacteria Enterococcus faecium (IC50 values 17 
4.2 and 4.8 µg/mL, respectively) and methicillin-resistant Staphylococcus aureus (MRSA, IC50 18 
values 5.3 and 7.2 µg/mL, respectively). Purification of the acidic fraction of the C. reticulata 19 
oleoresin yielded two dicarboxylic diterpene acids and the four main diterpene acids, 20 
comprising three different diterpene scaffolds. Interestingly, the activity was not restricted to a 21 
particular diterpene-type but rather depended on the compounds’ lipophilicity, with the most 22 
active constituent showing IC50 values of 1.6 (E. faecium) and 2.5 µg/mL (MRSA), 23 
respectively. Furthermore, ent-polyalthic acid, the major diterpenoid, was significantly active 24 
3 
against dermatophytes with IC50 values of 6.8 µg/mL (Trichophyton rubrum) and 4.3 µg/mL 1 
against (T. mentagrophytes). 2 
Conclusion: The present study proved the antimicrobial effects of the C. reticulata oleoresin 3 
and its diterpenoid constituents, confirming its wide use in folk medicine for the treatment of 4 
skin and urinary tract infections. The inhibitory activity of copaiba diterpenoids against 5 
dermatophytic fungi as well as the gram-positive bacteria E. faecium and MRSA is being 6 
reported for the first time, providing potential lead structures for the treatment of these clinically 7 
relevant bacterial strains. 8 
 9 
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4 
Introduction 1 
Copaifera reticulata Ducke (Fabaceae), is a tree growing in the tropical regions of Latin 2 
America (Veiga Junior and Pinto, 2002; Costa et al., 2015). The oleoresins of C. reticulata and 3 
a few other Copaifera species, which are obtained by perforation of the trunks during the rainy 4 
season, are commonly referred to as copaiba oil and traditionally used as a panacea by the 5 
indigenous population (Ohsaki et al., 1994; Veiga Junior and Pinto, 2002; Boaroto, 2014). 6 
Typical medicinal applications include wound and scar healing as well as treatments of skin 7 
and urinary tract infections, respiratory diseases, ulcers, rheumatism, herpes, tumours, and 8 
tetanus disease. Thus, rendering the oleoresin an important natural remedy for people without 9 
access to commercial drugs (Ohsaki et al., 1994; Veiga Junior and Pinto, 2002; Leandro et al., 10 
2012; Boaroto, 2014). Based on the comprehensive application in folk medicine, the oleoresin 11 
has been subject of various scientific studies aiming to prove its activity in different in vitro and 12 
in vivo models (Basile et al., 1988; Ohsaki et al., 1994; Veiga Junior et al., 2001; Lima et al., 13 
2003; Paiva et al., 2004; Carvalho et al., 2005; Gomes et al., 2007; Veiga Junior et al., 2007; 14 
Gomes et al., 2008; Santos et al., 2008a; Santos et al., 2008b; Brito et al., 2010; Gomes et al., 15 
2010; Santos Jr., 2010; Neto et al., 2011; Almeida et al., 2012; Dias et al. 2014; Bardaji et al., 16 
2016). 17 
Regarding the chemical composition, copaiba oleoresins have been reported to contain 18 
sesquiterpenes and diterpenes. Sesquiterpenes represent the main components with contents 19 
ranging from 58 to 98% by weight, depending on variable parameters such as species, growing 20 
area, and harvest time (Lima et al., 2003; Izumi et al., 2012; Souza Barbosa et al., 2013; Bardaji 21 
et al., 2016). In contrast to the diterpene pattern, the sesquiterpene pattern is stable and shows 22 
only limited variation between different Copaifera species, with β-caryophyllene usually being 23 
the major constituent (Leandro et al., 2012). However, for several C. reticulata samples of the 24 
Pará region, β-bisabolene has been reported to be the main compound (Zoghbi et al., 2009). 25 
5 
Both compounds, as many other major sesquiterpenes (e.g. α-humulene or caryophyllene oxide) 1 
are not restricted to the genus Copaifera and occur also in various other plant genera, such as 2 
Abies (Legault et al., 2003), Commiphora (Yeo et al., 2016), Eugenia (Zheng et al., 1992), 3 
Heterotheca (Kubo et al., 1996), Taiwania (He et al., 1997), and Zanthoxylum (Silva et al., 4 
2007). Therefore, previous pharmacological studies on pure compounds isolated from copaiba 5 
oleoresins focused on the more particular diterpenes, e.g. ent-copalic acid, ent-agathic acid (1), 6 
ent-kaurenoic acid (4), ent-polyalthic acid (3), and ent-hardwickiic acid (Leandro et al., 2012). 7 
Tincusi et al. (2002) isolated thirteen diterpenoids from the oleoresin of C. paupera. The 8 
authors found significant activity against gram-positive and gram-negative bacteria for ent-9 
copalic acid and ent-kaurenoic acid (4), with superior activity to cephotaxime against Bacillus 10 
subtilis. Cytotoxicity studies of the diterpene acids revealed no significant activity against colon 11 
cancer cells (HT-29), lung cancer cells (A-549), and melanoma cells (MEL-28) with IC50 12 
values above 10 μg/mL. Costa-Lotufo et al. (2002) reported moderate cytostatic activity for 13 
ent-kaurenoic acid (4) isolated from C. langsdorffii oleoresin, inhibiting the cell growth of 14 
leukemia cells (CEM) by 75%, breast cancer cells (MCF-7) and colon cancer cells (HCT-8) by 15 
45% each, at a test concentration of 78 μM. Cavalcanti et al. (2006) showed ent-kaurenoic (4) 16 
acid to induce DNA-damage in Chinese hamster fibroblasts (V79 cells), but reported the 17 
compound to possess poor therapeutic potential due to non-selective toxicity in a later study 18 
(Cavalcanti et al., 2009). Ent-copalic acid was reported to be active against five different 19 
Streptococcus species and Lactobacillus casei with MIC values ranging from 2.0 to 6.0 µg/mL 20 
(Souza et al., 2011). Ent-copalic acid was also active against amastigote forms of Trypanosoma 21 
cruzi together with 3β-hydroxycopalic acid and methyl copalate (Izumi et al., 2012). Ent-22 
polyalthic acid (3) was investigated against Schistosoma mansoni and found schistosomicidal 23 
with LD50 values from 33.4 to 41.7 µg/mL and to affect the production and the development of 24 
eggs (Borges et al., 2016).  25 
6 
Apart from the relatively few studies described above on pure compounds, the crude oleoresin 1 
showed biological activity in a multitude of investigations (Leandro et al., 2012; Trindade et 2 
al., 2018). Thus, the aim of the present study was to systematically evaluate the antimicrobial 3 
and cytotoxic properties of the Copaifera reticulata oleoresin and its chemical constituents. The 4 
cytotoxic effects were of special interest, because at the Veterinary Institute, Federal University 5 
of Pará (Brazil), the oleoresin is currently used for the topical treatment of malignant melanoma 6 
in horses. 7 
 8 
2. Materials and methods 9 
2.1. Phytochemical study 10 
2.1.1. Plant material and reagents  11 
Copaiba oleoresin was obtained through perforation of the trunk of a C. reticulata tree 12 
growing in Rondon do Pará, Brazil, in August 2016. The plant species was determined by the 13 
Brazilian Agricultural Research Corporation – Ministry of Agriculture, Livestock, and Food 14 
Supply. Methanol, water (both of LC-MS grade), and other (analytical grade) solvents were 15 
purchased from VWR International GmbH, Darmstadt, Germany. Solid phase extraction (SPE) 16 
columns (Chromabond SB 3 mL/500 mg) were obtained from Macherey-Nagel GmbH & Co. 17 
KG, Düren, Germany. Deuterated methanol (Lot P3021, 99.80%) for NMR spectroscopy was 18 
obtained from Euriso-top GmbH, Saarbrücken, Germany, and conventional 5 mm sample tubes 19 
were purchased from Rototec-Spintec GmbH, Griesheim, Germany. LC-MS grade formic acid 20 
was obtained from Sigma Aldrich Co., St. Louis, MO, USA. 21 
 22 
2.1.2. General experimental procedures 23 
GC-MS measurements were done on a TraceTSQ Duo system (Trace 1310 GC coupled to 24 
a Triple Stage Quadrupole Mass Spectrometer) equipped with a split/splitless (SSL) injector 25 
7 
and fitted with a TraceGOLD TG-SQC column (15 m x 0.25 mm i.d., film thickness 0.25 µm). 1 
UHPLC analyses were performed on a VWR-Hitachi Chromaster Ultra RS equipped with a 2 
6170 binary pump, 6270 autosampler, 6310 column oven, 6430 DAD, and a Sederé 100 3 
evaporative light scattering detector using a Phenomenex Luna Omega C18 column (100 × 2.1 4 
mm, 1.6 µm particle size). LC-MS analyses were carried out on a Shimadzu Nexera 2 Liquid 5 
chromatography connected to a LC-MS 8030 triple quadrupole mass spectrometer using 6 
electrospray ionization in the negative mode. Preparative MPLC was accomplished with a 7 
Buchi PrepChrom C-700 using a Buchi PrepChrom C18 column (250 × 30.0 mm, 15 µm 8 
particle size). NMR spectra were recorded using a Bruker Avance III 300 NMR spectrometer 9 
operating at 300 MHz for the proton channel and 75.5 MHz for the 13C channel with a 5 mm 10 
PABBO broad band probe with a z gradient unit.  11 
 12 
2.1.3. Solid phase extraction (SPE) and analytical chromatography 13 
For SPE, columns were equilibrated with two column volumes of n-hexane. 50.0 mg of 14 
oleoresin were dissolved in 500 µL dichloromethane, subjected to the SPE column and washed 15 
with three column volumes of n-hexane to yield the neutral fraction. For GC-MS analysis, the 16 
eluent was diluted to a volume of 10.0 mL with n-hexane (corresponding to 5.00 mg/mL 17 
oleoresin), for bioassays, the eluent was evaporated to dryness. Further elution of the dried SPE 18 
column with 5% formic acid in methanol yielded the acidic fraction, which was diluted to 10.0 19 
mL with methanol for UHPLC-ELSD analysis or evaporated to dryness for testing. Yields of 20 
the solid phase extraction were determined with 27.5 mg of neutral fraction (55%) and 22.5 mg 21 
of acidic fraction (45%).  22 
Conditions for GC-MS were: 70 °C to 220 °C at 3 °C/min, 220 °C for 15 min, 220 °C to 300 23 
°C at 60 °C/min, 300 °C for 2 min. Injector temperature was 250 °C, carrier gas was helium 24 
(1.2 mL/min), splitting ratio was 1:40 and detector temperature was 250 °C. Identification of 25 
8 
compounds was done by comparison with NIST database. Conditions for UHPLC-ELSD 1 
analysis are described in our previous study (Çiçek at al., 2018). 2 
 3 
2.1.4. Isolation of diterpene acids 4 
4.50 g oleoresin were dissolved in 300 mL diethyl ether and extracted five times with 50 5 
mL of 5% potassium hydroxide aqueous solution. The combined aqueous layers were acidified 6 
with 25% hydrochloric acid to pH 2 and extracted five times with 50 mL diethyl ether yielding 7 
1.77 g of diterpene acids after evaporation of the solvent. 0.78 g of the acidic fraction were 8 
chromatographed by preparative MPLC using isocratic elution with methanol-water (80:20 v/v) 9 
for 60 minutes followed by methanol-water (85:15 v/v) for another 60 minutes. The resulting 10 
192 fractions yielded ent-agathic acid (1, fractions 33-35, 4.8 mg), (13E)-ent-labd-8(17)-en-11 
15,18-dioic acid (2, fractions 41-47, 10.2 mg), ent-polyalthic acid (3, fractions 71-84, 124.4 12 
mg) and ent-kaurenoic acid (4, fractions 120-132, 35.9 mg), kolavenic acid (5, fractions 149-13 
152, 6.7 mg), and (13E)-ent-labda-7,13-dien-15-oic acid (6, fractions 159-165, 4.9 mg) (Fig. 14 
1). Structures of the isolated compounds were elucidated by comparison of their MS and NMR 15 
spectra with the literature data (Lin et al., 1998; Salah et al., 2003; Xiang et al., 2004; Souza et 16 
al., 2010;). 17 
  18 
2.2. Biological activity testing 19 
2.2.1. Antibacterial activity 20 
The samples were tested against the ESKAPE panel of multidrug resistant bacterial human 21 
pathogens, including the gram-positive bacteria Enterococcus faecium and methillicin-resistant 22 
Staphylococcus aureus (MRSA), and the gram-negative bacteria Klebsiella pneumoniae, 23 
Acinetobacter baumannii, Pseudomonas aeruginosa and Escherichia coli. As inhibitory effects 24 
9 
were only observed for the Gram-positive strains, the respective bioassays are described in the 1 
following.   2 
Staphylococcus aureus DSM 18827 and Enterococcus faecium DSM 20477 were purchased 3 
from Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 4 
Braunschweig, Germany. The cultivation of MRSA took place in TSB medium (1.2% tryptic 5 
soy broth, 0.5% NaCl) and E. faecium was cultivated in M92 medium (3% trypticase soy broth, 6 
0.3% yeast extract, pH 7.0-7.2). Overnight cultures of the test organisms were prepared and 7 
diluted to an optical density (600 nm) of 0.01. To prepare the assay, the test samples (20 mg/mL 8 
DMSO stock solution) were dissolved in medium and transferred into a 96-well microtiter plate 9 
and 200 µL of the cell suspension cultures were added to each well. The final assay 10 
concentration of the substances was 100 µg/mL. The inoculated microplates were incubated for 11 
5 hours at 37 °C and 200 rpm (E. faecium without shaking). To detect the inhibitory effect of 12 
the substances against MRSA 10 µL of a resazurin solution (0.3 mg/mL phosphate-buffered 13 
saline) was added to the microplates and incubated again for 5-30 min before the fluorescence 14 
signal (560 nm/590 nm) was measured using the microplate reader (Tecan Infinite M200). For 15 
E. faecium the pH indicator bromocresol purple was used to determine the acidification caused 16 
by growing. The resulting values were compared with a positive control (chloramphenicol for 17 
MRSA and ampicillin for E. faecium) and a negative control (no compound) on the same plate. 18 
For IC50 determination, a dilution series was prepared and the IC50 value was calculated by 19 
GraphPad Prism as the concentration that show 50% inhibition of viability on the basis of a 20 
negative control (no compound). 21 
 22 
2.2.2. Activity against dermatophytic fungi 23 
Trichophyton rubrum I/95 and T. mentagrophytes 204/09 (patient isolates from Kiel 24 
University Hospital) were cultivated for two weeks on Sabouraud agar (1% peptone, 2% 25 
10 
glucose, 1.5% agar-agar, pH 5.6). A suspension of 5*104 spores/mL Sabouraud medium was 1 
prepared and added to each well of a microplate containing the test samples, which were 2 
transferred as described before (bacterial assay). After incubation for 72 hours at 28 °C and 120 3 
rpm the optical density at 600 nm was measured using the microplate reader. The resulting 4 
values were compared with a positive (clotrimazol) and a negative control (no compound) on 5 
the same plate. For IC50 determination the test samples were diluted as described before 6 
(bacterial assay) and calculated as the concentration that shows 50% inhibition of growing. 7 
 8 
2.2.3. Cytotoxic activity 9 
The sensitivity of liver cancer cell line HEP-G2 (DSMZ, Braunschweig, Germany), 10 
colorectal adenocarcinoma cell line HT-29 (DSMZ, Braunschweig, Germany), malignant 11 
melanoma cell line A-375 (CLS, Eppelheim, Germany), colon cancer cell line HCT-116 12 
(DSMZ, Braunschweig, Germany), lung carcinoma cell line A-549 (CLS, Eppelheim, 13 
Germany), human breast cancer line MDA-MB-231 (CLS, Eppelheim, Germany), and the non-14 
cancerous human keratinocyte line HaCaT (CLS, Eppelheim, Germany)  to the compounds was 15 
evaluated by monitoring the metabolic activity using the CellTiterBlue cell viability assay 16 
(Promega, Mannheim, Germany). HEP-G2, HT-29 and HaCaT cells were cultivated in RPMI 17 
medium, A549 and MDA-MB-231 cells in DMEM:Ham’s F12 medium (1:1) supplemented 18 
with 15 mM HEPES, and A-375 and HCT-116 cells were cultivated in DMEM medium 19 
supplemented with 4.5 g/L D-glucose and 110 mg/L sodium pyruvate. All media were 20 
supplemented with L-glutamine, 10% fetal bovine serum, 100 U/mL penicillin and 100 µg/mL 21 
streptomycin. The cultures were maintained at 37 °C under a humidified atmosphere and 5% 22 
CO2. The cell lines were transferred every 3 or 4 days. For experimental procedure, cells were 23 
seeded in 96-well plates at concentration of 10,000 cells per well in RPMI. After 24 hours 24 
incubation, the medium was removed and 100 µL of the test sample were adjusted to a final 25 
11 
concentration of 100 µg/mL by diluting with growth medium. Doxorubicin, as a standard 1 
therapeutic drug was used as a positive control. Following compound addition, plates were 2 
cultivated for 24 hours at 37 °C. Afterwards, the assay was performed according to the 3 
manufacturer’s instructions and measured using the microplate reader at excitation with 560 4 
nm and emission of 590 nm. For the determination of IC50 values, a dilution series of the 5 
compounds was prepared and tested as described before. IC50 value was calculated as the 6 
concentration that shows 50% inhibition of the viability. 7 
 8 
2.2.4. Statistical analysis 9 
Results were expressed as mean ± SD. Statistical significance was determined by one-way 10 
analysis of variance (ANOVA). Differences were considered significant if p < 0.05. 11 
 12 
3. Results  13 
3.1. Preliminary tests  14 
Bioassays used in this study comprised two clinically relevant bacterial strains, two 15 
dermatophyte strains, six different cancer cell lines, and one non-cancerous cell line. First tests 16 
were accomplished using the oleoresin as well as its neutral and acidic fraction, which were 17 
separated by anion exchange SPE. Cytotoxicity studies showed only moderate activity for the 18 
oleoresin (IC50 values from 72.1 to 87.5 µg/mL), which was more pronounced in the neutral 19 
fraction (IC50 values from 52.2 to 77.6 µg/mL) and less pronounced in the acidic fraction (IC50 20 
values from 84.7 to >100 µg/mL). In contrast, significant antibacterial results were observed 21 
for the oleoresin and the acidic fraction, with IC50 values of 4.2 and 4.8 µg/mL against E. 22 
faecium, and 5.3 and 7.2 µg/mL against MRSA, respectively, whereas the neutral fraction was 23 
only moderately active (IC50 values from 52.5 to 87.1 µg/mL). Thus, our study concentrated on 24 
the isolation of diterpene acids and the assessment of their biological activity. Additionally, the 25 
12 
neutral fraction was investigated for its array of sesquiterpenes by GC-MS, but was not further 1 
separated due to its moderate antimicrobial and cytotoxic activity. 2 
 3 
3.2. Isolation of diterpene acids 4 
To separate the diterpene acids from the neutral constituents in a preparative scale, the 5 
oleoresin was partitioned using potassium hydroxide and diethyl ether (Romero et al., 2009). 6 
After UHPLC analysis of the partition showed a constituent pattern comparable to that of the 7 
acidic fraction obtained by SPE, the acids were chromatographed using reversed phase MPLC. 8 
Isocratic elution with methanol-water (80:20 v/v) yielded dicarboxylic acids ent-agathic acid 9 
(1) and (13E)-ent-labd-8(17)-en-15,18-dioic acid (2) as well as ent-polyalthic acid (3), the 10 
major diterpenoid of the C. reticulata oleoresin. Subsequent isocratic elution with methanol-11 
water (85:15 v/v) resulted in the isolation of ent-kaurenoic acid (4), kolavenic acid (5), and 12 
(13E)-ent-labda-7,13-dien-15-oic acid (6) (Fig. 1). With the exception of ent-copalic acid, the 13 
isolated compounds comprised all relevant diterpene acids in the C. reticulata oleoresin. 14 
Moreover, all three types of diterpene scaffolds known from copaiba oleoresins, labdane-type 15 
(compounds 1, 2, 3, and 6), kaurane-type (4), and clerodane-type (5) diterpenes could be 16 
investigated. All compounds were tested for their antimicrobial and cytotoxic potential, except 17 
for compound 6, which was not investigated on dermatophytes because of the minute amounts 18 
of the compound isolated. 19 
 20 
3.3. Analysis of the neutral and acidic fractions 21 
The neutral fraction was analyzed by GC-MS for its composition and the content of the main 22 
sesquiterpenes. Of the 35 present compounds, only eleven showed relative amounts of more 23 
than 1%, with β-bisabolene (42.3%), caryophyllene oxide (18.7%), cis-α-bergamotene (11.7%), 24 
and α-caryophyllene (10.0%) as the main constituents. UHPLC-ELSD analysis of the acidic 25 
13 
fractions gave the following relative amounts: ent-agathic acid (1, 0.92%), (13E)-ent-labd-1 
8(17)-en-15,18-dioic acid (2, 1.96%), ent-polyalthic acid (3, 51.6%), ent-kaurenoic acid (4, 2 
21.6%), kolavenic acid (5, 8.52%), and (13E)-ent-labda-7,13-dien-15-oic acid (6, 10.8%). In 3 
total, the neutral fraction accounted for 55% of the oleoresin and the acidic fraction for 45%. 4 
 5 
3.4. Antimicrobial effects 6 
As mentioned above, antibacterial assays resulted in significant effects for the crude 7 
oleoresin, with IC50 values of 4.2 µg/mL against E. faecium and 5.3 µg/mL against MRSA. The 8 
antimicrobial activity was retained by the acidic fraction, with IC50 values of 4.8 µg/mL against 9 
E. faecium and 7.2 µg/mL against MRSA, while the neutral fraction showed poor activity with 10 
IC50 values of 52.5 and 75.9 µg/mL, respectively (Table 1). Regarding the pure diterpene acids, 11 
except for the ent-agathic acid (1), which had no antibacterial activity, all other pure compounds 12 
had significant activity against E. faecium and MRSA. Notably, the antibacterial activity of the 13 
isolated diterpenoids increased with their lipophilicity, showing higher IC50 values for 14 
dicarboxylic acids 1 and 2 as well as for ent-polyalthic acid (3), while compounds 4 to 6 had 15 
very low IC50 values.  16 
Due to the use of copaiba for the treatment of various skin infections in Brazilian traditional 17 
medicine, we also assessed its inhibitory potential against two dermatophytic fungi from the 18 
genus Trichophyton that cause athlete’s foot, nail infection, ringworm and itches in head and 19 
body skin. Here, the crude oleoresin had moderate antifungal activity (IC50 value of 39.8 µg/mL 20 
against T. rubrum and 15.1 µg/mL against T. mentagrophytes) and the acidic fraction was again 21 
more active (IC50 values 55.0 and 31.6 µg/mL, respectively) than the neutral fraction (IC50 22 
values 87.1 and 63.1 µg/mL, respectively). Among the five tested compounds, ent-polyalthic 23 
acid (3) was the only metabolite that showed pronounced antifungal effects (IC50 values 6.8 24 
µg/mL against T. rubrum and 4.3 µg/mL against T. mentagrophytes, respectively), while the 25 
14 
other diterpenoids displayed moderate to low inhibitory potential (IC50 values ranging from 1 
15.5 to 91.2 µg/mL, Table 1) . 2 
 3 
3.5. Cytotoxic effects 4 
In the cytotoxicity tests, the oleoresin showed IC50 values ranging from 72.1 µg/mL to 87.5 5 
µg/mL against the six tested cancer cell lines. However, its cytotoxicity against the non-6 
cancerous human keratinocytes (HaCaT) cells was equipotent (IC50 86.5 µg/mL, Table 2). The 7 
neutral fraction showed better activity against all cell lines than the crude oleoresin (IC50 values 8 
from 52.2 to 77.6 µg/mL), whereas the acidic fraction was only marginally active or inactive at 9 
the highest concentration tested (100 µg/mL). Regarding the cytotoxicity of the pure 10 
compounds, the dicarboxylic acids 1 and 2 were inactive at the highest concentration (100 11 
µg/mL). The remaining compounds exerted moderate toxicity against cancer cell lines, which 12 
was equal to their cytotoxicity on non-cancerous HaCaT cells, pointing out a non-specific 13 
toxicity rather than a selective toxicity. Ent-kaurenoic acid (4) was most effective against A-14 
375, HepG2, HT-29, HCT-116, and MB-231 cell lines with IC50 values from 50.2 to 65.2 15 
µg/mL, whereas kolavenic acid (5) showed the highest activity against the A-549 cell line, with 16 
an IC50 value of 58.9 µg/mL. However, the compound showed the same toxicity towards HaCaT 17 
cells, with an IC50 value of 56.0 µg/mL.   18 
 19 
4. Discussion 20 
4.1. Cytotoxic effects 21 
Several studies dealt with the cytotoxic and anticancer properties of copaiba oleoresin, its 22 
fractions and pure compounds. Most notable activities were found for β-caryophyllene and the 23 
diterpene kolavenol. β-Caryophyllene was active against HeLa, BT-20, B-16 and HTB cells, 24 
with IC50 values ranging from 3.86 to 4.86 µg/mL (Kubo et al., 1996). In two studies on the 25 
15 
cytotoxic potential of ent-kaurenoic acid (4), the compound was found active against CEM 1 
leukemic cells as well as MCF-7 breast and HCT-8 colon cancer cells, but the activity was 2 
found to be non-selective (Costa-Lotufo et al., 2002; Cavalcanti et al., 2009). Ent-kaurenoic 3 
acid (4) and six other diterpene acids (including compounds 2 and 3) were also part of a 4 
cytotoxicity study on four different cancer cell lines, but none of the compounds showed 5 
significant activity (Tincusi et al., 2002).  6 
The weak activity of diterpene acids on human cancer cell lines was also evident in our own 7 
study, where IC50 values of all compounds exceeded 50 µg/mL. The neutral fraction did not 8 
show superior results either, which was surprising with regards to the good effects observed for 9 
the treatment of malignant horse melanoma at Pará University. Therefore, the neutral fraction 10 
was analysed for its contents on sesquiterpenes by GC-MS, revealing that the oleoresin 11 
investigated in our study is of the β-bisabolene-type (Zoghbi et al., 2009), in contrast to the 12 
oleoresins of other Copaifera species, which were reported to contain up to 60% of β-13 
caryophyllene (Trindade et al., 2018).  14 
β-Bisabolene was found to exhibit cytotoxic effects on breast cancer cell lines, with IC50 15 
values from 66.9 to 98.4 µg/mL (Yeo et al., 2015). These values were comparable to the IC50 16 
values observed in our own study and (together with the relatively small quantity of β-17 
caryophyllene) a possible reason for the low in vitro activity of our oleoresin. The fact that the 18 
use of oleoresins for the treatment of horses is not restricted to C. reticulata, nor to a certain 19 
chemotype, supports this theory. Because the horses at Pará University are treated topically, 20 
where the responsible (lipophilic) compounds exhibit their effect after passive diffusion into 21 
the tumour tissue, low solubility in culture media and thus reduced activity might be an 22 
alternative explanation. This effect is confirmed by previous anticancer studies on copaiba 23 
oleoresin, where the more pronounced effects were observed in vivo, such as activity against 24 
Walker sarcoma in rats (Moraes et al. 1997), IMC carcinoma in mice (Ohsaki et al, 1994), Sp2/0 25 
16 
murine myeloma (Lima et al., 2003), or antineoplastic properties against Ehrlich tumours 1 
(Gomes et al., 2008). These polarity issues will be more relevant for the sesquiterpenes than for 2 
the more polar diterpene acids. 3 
 4 
4.2. Antimicrobial effects 5 
Due to its wide use in folk medicine, copaiba oil was extensively studied for its antimicrobial 6 
activity (Leandro et al., 2002). However, only few reports have been performed on the activity 7 
of defined compounds isolated from the oleoresin. Tincusi et al. (2002) found significant 8 
activities for ent-kaurenoic acid (4) and ent-copalic acid against B. subtilis, S. aureus and S. 9 
epidermidis, with MIC values < 10 µg/mL for S. aureus and < 6 µg/mL for B. subtilis and S. 10 
epidermidis, respectively. Ent-copalic acid was furthermore active against five different 11 
Streptococcus species as well as Lactobacillus casei, with MIC values < 6 µg/mL and minimum 12 
bactericidal concentrations below 15 µg/mL, respectively (Souza et al., 2011). Santos et al. 13 
(2008b) investigated the effect of the oleoresin obtained from eight different Copaifera species 14 
on their activity against S. aureus, MRSA, S. epidermidis, B. subtilis and E. faecalis. In the 15 
same study, C. reticulata oleoresin obtained from two different regions was tested and showed 16 
different results for different geographic regions of origin. The oleoresin obtained from Acre 17 
(western Brazil) showed moderate activity against MRSA and good activity against the 18 
remaining bacterial strains, while oleoresin collected in Pará (northern Brazil) was only 19 
moderately active against B. subtilis and E. faecalis, and inactive against the other strains. In 20 
the same study, antifungal properties were investigated, but C. reticulata oleoresin was neither 21 
active against T. rubrum or T. mentagrophytes, nor against any of the other tested fungi or 22 
yeasts.  23 
Interestingly, in our own study good activity for the C. reticulata oleoresin was observed 24 
against T. mentagrophytes and still moderate activity against T. rubrum. Ent-polyalthic acid 25 
17 
(3), the main diterpene acid that accounts around 23% of the oleoresin (Çiçek et al., 2018), was 1 
found responsible for this effect as the compound showed IC50 values of 4.3 (T. 2 
mentagrophytes) and 6.8 µg/mL (T. rubrum). Bearing a heteroaromatic substructure ent-3 
polyalthic acid (3) significantly differs from the remaining diterpene acids in our study. This 4 
structural difference and its much higher activity render the furylic moiety a possible key feature 5 
for antifungal activity of diterpene acids, at least with regards to Trichophyton sp. In this sense, 6 
investigations of ent-hardwickiic acid, another furanoditerpene acid known from copaiba, or 7 
oleoresins containing this compound would be of interest. Regarding the use of copaiba for the 8 
treatment of skin infections, the observed antifungal activity might provide a scientific 9 
explanation for its beneficial effect. 10 
Even more pronounced than the activity against dermatophytes, was the effect of C. 11 
reticulata oleoresin against E. faecium and MRSA, with IC50 values of 4.2 and 5.3 µg/mL, 12 
respectively. E. faecium causes urinary tract infections, whereas MRSA mainly leads to skin 13 
infections, but can also affect the respiratory system. Regarding the isolated diterpenoids, all 14 
tested compounds except ent-agathic acid (1) were active. However, the antibacterial effects of 15 
lipophilic compounds 4, 5 and 6 were more pronounced. Interestingly, these three compounds 16 
represent all three types of copaiba diterpenes, kaurane-type, clerodane-type, and labdane-type 17 
diterpenes, thus indicating that the antibacterial activity is not restricted to a certain scaffold. 18 
As E. faecium and other Enterococcus species can cause urinary tract infections, another illness 19 
that is traditionally treated with copaiba, our results give a possible scientific prove for its effect. 20 
Similar to MRSA, E. faecium is prone to develop resistances against antibiotics. Therefore, the 21 
results of our study reveal that the oleoresin and the pure diterpene components of copaiba are 22 
useful in primary health care to treat bacterial and fungal infections. Several pure components 23 
also have potential to serve as lead structures for the treatment of clinically relevant bacterial 24 
strains, which is one of the major global challenges of the 21st century. 25 
18 
 1 
5. Conclusion 2 
In the present study, the biological activity of the Copaifera reticulata oleoresin was 3 
systematically analysed with regards to its neutral and acidic fractions and constituents. While 4 
reports on cytotoxic activities were not corroborated by our own in vitro experiments, we 5 
proved its antimicrobial activity and identified the compounds responsible for the observed 6 
pharmacological effects. We demonstrated that ent-polyalthic acid (3) was significantly active 7 
against both dermatophytic fungi, Trichophyton rubrum and T. mentagrophytes, which might 8 
be related to its furylic substructure. Furthermore, ent-kaurenoic acid (4), kolavenic acid (5), 9 
and (13E)-ent-labda-7,13-dien-15-oic acid (6) were found to be very active against E. faecium 10 
and MRSA. Differing antimicrobial effects observed for structurally different diterpene acids 11 
yield new details about the health-beneficial effects of copaiba. Thus, supporting the wide 12 
medical use of the chemically divers genus Copaifera. Giving a possible explanation for the 13 
ethnopharmacological use of the C. reticulata oleoresin for the treatment of skin and urinary 14 
tract infections, the present study moreover shows first reports for the activity of copaiba 15 
diterpenoids against Trichophyton dermatophytes and two clinically relevant bacterial strains. 16 
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Figure captions  1 
 2 
Figure 1: Chemical structures of isolated compounds: ent-agathic acid (1), (13E)-ent-labd-3 
8(17)-en-15,18-dioic acid (2), ent-polyalthic acid (3), ent-kaurenoic acid (4), kolavenic acid (5), 4 
and (13E)-ent-labda-7,13-dien-15-oic acid (6).  5 
 6 
 7 
Figure 2: GC-MS chromatogram of the neutral copaiba fraction. Main sesquiterpenes were β-8 
caryophyllene (A), cis-α-bergamotene (B), β-bisabolene (C) and caryophyllene oxide (D). 9 
 10 
  11 
21 
Table 1 1 
Antimicrobial effects of the crude oleoresin, its neutral and acidic fractions, and compounds 1-2 
6. The IC50 values are in µg/mL., n.t. means not tested. Positive controls were ampicillin (E. 3 
faecium), chloramphenicol (MRSA) and clotrimazole (T. rubrum and T. mentagrophytes).  4 
  E. faecium MRSA T. rubrum T. mentagrophytes 
Crude oleoresin   4.2 ± 0.1   5.3 ± 0.3 39.8 ± 1.8 15.1 ± 1.2 
Neutral fraction 52.5 ± 2.4 75.9 ± 7.4 87.1 ± 1.0 63.1 ± 2.9 
Acidic fraction   4.8 ± 0.1   7.2 ± 0.6 55.0 ± 3.9 31.6 ± 9.3 
Compound 1 > 100 > 100 41.7 ± 0.5 30.2 ± 0.3 
Compound 2   9.3 ± 0.3 10.7 ± 1.1 44.7 ± 3.0 38.0 ± 0.5 
Compound 3   8.5 ± 0.4   8.9 ± 0.8 6.8 ± 0.1 4.3 ± 0.1 
Compound 4   2.3 ± 0.2a,b   3.4 ± 0.2 a,b 70.8 ± 1.6 15.5 ± 0.7 
Compound 5   2.2 ± 0.1 a,b   3.0 ± 0.2 a,b 66.0 ± 0.8 91.2 ± 5.9 
Compound 6   1.6 ± 0.1 a,b,d   2.5 ± 0.3 a,b n.t. n.t. 
Positive control   0.4 ± 0.1 a,b,c,d,e   1.2 ± 0.1 a,b,c,d,e 0.1 ± 0.0 0.1 ± 0.0 
 5 
Each value represents the mean ± SD. Significance was determined by one-way ANOVA for 6 
compounds 2-6 against E. faecium and MRSA.  7 
a p < 0.05 as compared with compound 2. 8 
b p < 0.05 as compared with compound 3. 9 
c p < 0.05 as compared with compound 4. 10 
d p < 0.05 as compared with compound 5. 11 
e p < 0.05 as compared with compound 6. 12 
 13 
22 
Table 2 1 
Cytotoxic effects of the crude oleoresin, its neutral and acidic fraction, and compounds 1-6. The IC50 values are in µg/mL. Doxorubicin was used 2 
as positive control. 3 
 
A-375 HepG2 HT-29 HCT-116 A-549 MB-231 HaCaT 
Crude oleoresin 80.2 ± 0.5 79.3 ± 0.3 83.8 ± 1.2 72.1 ± 0.6 87.5 ± 0.3 85.5 ± 0.1 86.5 ± 0.1 
Neutral fraction 55.0 ± 0.8 59.2 ± 4.5 52.2 ± 2.5 53.3 ± 0.1 77.6 ± 2.2 54.3 ± 0.5 67.6 ± 7.8 
Acidic fraction 85.3 ± 0.2 84.7 ± 0.9 92.9 ± 0.8 87.9 ± 0.3 > 100 91.4 ± 0.5 > 100 
Compound 1 > 100 > 100 > 100 > 100 > 100 > 100 > 100 
Compound 2 > 100 > 100 > 100 > 100 > 100 > 100 > 100 
Compound 3 78.3 ± 1.3 83.2 ± 1.3 86.1 ± 1.4 66.2 ± 0.7 91.2 ± 0.5 96.4 ± 1.1 87.5 ± 0.8 
Compound 4 55.7 ± 0.5 59.4 ± 0.2 61.8 ± 0.6 50.2 ± 4.1 79.6 ± 1.7 65.2 ± 0.3 69.0 ± 3.7 
Compound 5 62.2 ± 0.7 68.9 ± 0.7 63.2 ± 0.5 62.4 ± 0.3 58.9 ± 0.5 72.8 ± 0.1 56.0 ± 0.3 
Compound 6 > 50 > 50 > 50 > 50 > 50 > 50 > 50 
Positive control 15.9 ± 2.2 14.9 ± 1.7 8.9 ± 0.5 10.6 ± 1.9 31.4 ± 4.4 15.2 ± 0.2 10.0 ± 4.5 
 4 
Each value represents the mean ± SD.  5 
 6 
 7 
 8 
 9 
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